SCHEMBL14969788

SCHEMBL14969788

CC(O)CC(O)CC(O)CC(O)CC(C)O

nearest known ligand 0.44

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.44
TDP1 Q9NUW8 1/20 0.44
ALDH1A1 P00352 2/20 0.41
LMNA P02545 1/20 0.36
MAPK1 P28482 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12560763 1.00 TSHR (0.44) TSHRTDP1ALDH1A1LMNAMAPK1
SCHEMBL19449972 1.00 TSHR (0.44) TSHRTDP1ALDH1A1LMNAMAPK1
SCHEMBL12915076 1.00 TSHR (0.44) TSHRTDP1ALDH1A1LMNAMAPK1
SCHEMBL19450212 1.00 TSHR (0.44) TSHRTDP1ALDH1A1LMNAMAPK1
SCHEMBL19450283 1.00 TSHR (0.44) TSHRTDP1ALDH1A1LMNAMAPK1
SCHEMBL1535121 0.96 TSHR (0.47) TSHRTDP1ALDH1A1LMNAMAPK1
SCHEMBL16675541 0.90 TSHR (0.37) TSHRTDP1ALDH1A1MAPK1
SCHEMBL10168446 0.87 TSHR (0.50) TSHRTDP1ALDH1A1
SCHEMBL827872 0.87 TDP1 (0.50) TSHRTDP1ALDH1A1LMNA
SCHEMBL15089438 0.87 TDP1 (0.50) TSHRTDP1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170349718-A1 BINDER SYSTEM OWENS CORNING INTELLECTUAL CAPITAL, LLC 2017-12-07 US disclosed
US-9651528-B2 Diarylamine-based fluorogenic probes for detection of peroxynitrite THE UNIVERSITY OF HONG KONG (CN) 2017-05-16 US disclosed
US-20150217020-A1 Lung Volume Reduction Therapy Using Crosslinked Non-Natural Polymers PULMONX CORPORATION 2015-08-06 US disclosed
US-9006340-B2 Lung volume reduction therapy using crosslinked non-natural polymers AERIS THERAPEUTICS, LLC (US) 2015-04-14 US disclosed
US-8445589-B2 Lung volume reduction therapy using crosslinked non-natural polymers AERIS THERAPEUTICS, LLC (US) 2013-05-21 US disclosed